Opko Health (OPK) Net Income towards Common Stockholders (2010 - 2026)

Opko Health has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$54.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 18.87% year-over-year to -$54.8 million; the trailing twelve-month figure through Mar 2026 stood at -$227.9 million (down 329.86% YoY), and the FY2025 full-year result was -$240.6 million, down 525.68% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$54.8 million, down from -$46.2 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $24.9 million in Q3 2024, with the low at -$159.6 million in Q4 2022.
• Historically, Net Income towards Common Stockholders has averaged -$59.6 million across 5 years, with a median of -$60.9 million in 2022.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 129.48% — and 2025, when it slumped 1340.62%.
• Opko Health's Net Income towards Common Stockholders stood at -$159.6 million in 2022, then jumped by 58.35% to -$66.5 million in 2023, then jumped by 137.45% to $24.9 million in 2024, then plunged by 285.75% to -$46.2 million in 2025, then slipped by 18.61% to -$54.8 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$54.8 million (Q1 2026), -$46.2 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.